EP2701778

BIOGEN IDEC MA INC.
Application Number
EP12716975A
Filing Date
Apr 16, 2012
Status
Patent Maintained As Amended
Sep 15, 2023
Grant Date
Oct 18, 2023
External Links
Slate, Register

Biblio Summary

The patent EP2701778B2 was granted on Oct 18, 2023 by Biogen Idec Ma Inc. The patent is currently Patent Maintained As Amended.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBBApr 7, 2021ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBApr 1, 2021ADMISSIBLE

The table below shows the patents of Biogen Idec Ma Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2645106Methods And Products For Evaluating An Immune Response To A Therapeutic AgentOct 2, 20241
EP2653873Compositions And Uses For Treating Multiple SclerosisAug 24, 202214
EP2870250Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses ThereofJun 29, 20222

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.